| Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival R Adam, V Delvart, G Pascal, A Valeanu, D Castaing, D Azoulay, ... Annals of surgery 240 (4), 644-658, 2004 | 2050 | 2004 |
| Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil–leucovorin as first-line treatment of metastatic colorectal cancer S Giacchetti, B Perpoint, R Zidani, N Le Bail, R Faggiuolo, C Focan, ... Journal of clinical oncology 18 (1), 136-136, 2000 | 1838 | 2000 |
| Long-term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and surgery S Giacchetti, M Itzhaki, G Gruia, R Adam, R Zidani, F Kunstlinger, ... Annals of Oncology 10 (6), 663-669, 1999 | 831 | 1999 |
| Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases T Aloia, M Sebagh, M Plasse, V Karam, F Lévi, S Giacchetti, D Azoulay, ... Journal of clinical oncology 24 (31), 4983-4990, 2006 | 669 | 2006 |
| Marked 24-h rest/activity rhythms are associated with better quality of life, better response, and longer survival in patients with metastatic colorectal cancer and good … MC Mormont, J Waterhouse, P Bleuzen, S Giacchetti, A Jami, A Bogdan, ... Clinical cancer research 6 (8), 3038-3045, 2000 | 531 | 2000 |
| Correlation of high 18F-FDG uptake to clinical, pathological and biological prognostic factors in breast cancer D Groheux, S Giacchetti, JL Moretti, R Porcher, M Espié, J Lehmann-Che, ... European journal of nuclear medicine and molecular imaging 38, 426-435, 2011 | 435 | 2011 |
| Is liver resection justified for patients with hepatic metastases from breast cancer? R Adam, T Aloia, J Krissat, MP Bralet, B Paule, S Giacchetti, V Delvart, ... Annals of surgery 244 (6), 897-908, 2006 | 344 | 2006 |
| Single circulating tumor cell detection and overall survival in nonmetastatic breast cancer FC Bidard, C Mathiot, S Delaloge, E Brain, S Giachetti, P De Cremoux, ... Annals of Oncology 21 (4), 729-733, 2010 | 305 | 2010 |
| Performance of FDG PET/CT in the clinical management of breast cancer D Groheux, M Espié, S Giacchetti, E Hindié Radiology 266 (2), 388-405, 2013 | 300 | 2013 |
| p53 in breast cancer subtypes and new insights into response to chemotherapy P Bertheau, J Lehmann-Che, M Varna, A Dumay, B Poirot, R Porcher, ... The Breast 22, S27-S29, 2013 | 267 | 2013 |
| Phase III trial comparing 4-day chronomodulated therapy versus 2-day conventional delivery of fluorouracil, leucovorin, and oxaliplatin as first-line chemotherapy of metastatic … S Giacchetti, G Bjarnason, C Garufi, D Genet, S Iacobelli, M Tampellini, ... Journal of clinical oncology 24 (22), 3562-3569, 2006 | 235 | 2006 |
| Circadian rhythm in rest and activity: a biological correlate of quality of life and a predictor of survival in patients with metastatic colorectal cancer PF Innominato, C Focan, T Gorlia, T Moreau, C Garufi, J Waterhouse, ... Cancer research 69 (11), 4700-4707, 2009 | 232 | 2009 |
| Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer CE Geyer Jr, JE Garber, RD Gelber, G Yothers, M Taboada, L Ross, ... Annals of oncology 33 (12), 1250-1268, 2022 | 230 | 2022 |
| Implications of circadian clocks for the rhythmic delivery of cancer therapeutics F Lévi, C Focan, A Karaboué, V de la Valette, D Focan-Henrard, B Baron, ... Advanced drug delivery reviews 59 (9-10), 1015-1035, 2007 | 206 | 2007 |
| Prognostic Impact of 18FDG-PET-CT Findings in Clinical Stage III and IIB Breast Cancer D Groheux, E Hindié, M Delord, S Giacchetti, A Hamy, C de Bazelaire, ... Journal of the National Cancer Institute 104 (24), 1879-1887, 2012 | 172 | 2012 |
| 18F-FDG PET/CT in staging patients with locally advanced or inflammatory breast cancer: comparison to conventional staging D Groheux, S Giacchetti, M Delord, E Hindié, L Vercellino, C Cuvier, ... Journal of Nuclear Medicine 54 (1), 5-11, 2013 | 164 | 2013 |
| Effect of 18F-FDG PET/CT imaging in patients with clinical stage II and III breast cancer D Groheux, JL Moretti, G Baillet, M Espie, S Giacchetti, E Hindie, ... International Journal of Radiation Oncology* Biology* Physics 71 (3), 695-704, 2008 | 161 | 2008 |
| Sex moderates circadian chemotherapy effects on survival of patients with metastatic colorectal cancer: a meta-analysis S Giacchetti, PA Dugué, PF Innominato, GA Bjarnason, C Focan, C Garufi, ... Annals of oncology 23 (12), 3110-3116, 2012 | 147 | 2012 |
| 6 months versus 12 months of adjuvant trastuzumab in early breast cancer (PHARE): final analysis of a multicentre, open-label, phase 3 randomised trial X Pivot, G Romieu, M Debled, JY Pierga, P Kerbrat, T Bachelot, ... The Lancet 393 (10191), 2591-2598, 2019 | 138 | 2019 |
| Prediction of overall survival through circadian rest‐activity monitoring during chemotherapy for metastatic colorectal cancer PF Innominato, S Giacchetti, GA Bjarnason, C Focan, C Garufi, B Coudert, ... International Journal of Cancer 131 (11), 2684-2692, 2012 | 136 | 2012 |
